Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis

被引:22
|
作者
Laura Alberti, Maria [1 ]
Malet Ruiz, Jose Maria [1 ]
Eduardo Fernandez, Martin [1 ]
Fassola, Leandro [1 ]
Caro, Fabian [1 ]
Buendia Roldan, Ivette [2 ]
Paulin, Francisco [1 ]
机构
[1] Hosp Maria Ferrer Buenos Aires, Interstitial Lung Dis Clin, Buenos Aires, DF, Argentina
[2] Inst Nacl Enfermedades Resp INER Ismael Cosio Vil, Buenos Aires, DF, Argentina
来源
PULMONOLOGY | 2020年 / 26卷 / 01期
关键词
Chronic hypersensitivity pneumonitis; Idiopathic pulmonary fibrosis; Extrinsic allergic alveolitis; Interstitial lung disease; INTERSTITIAL PNEUMONIA; CT FINDINGS; DIAGNOSIS; AZATHIOPRINE;
D O I
10.1016/j.pulmoe.2019.08.007
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease with limited treatment response and bad prognosis. Sometimes it is indistinguishable from idiopathic pulmonary fibrosis (IPF) becoming one of the main differential diagnosis. The aim of our study is to compare survival and functional decline between these two entities. Methods: Survival and functional decline more than 10% in FVC were compared using Kaplan Meier (KM) method between patients with CHP and IPF. Cox proportional hazard analysis was used to identify independent predictors of survival and functional decline. Results: 146 patients were included, 54 with CHP and 92 with IPF. KM rate for 2 years survival was 0.71 (CI 95% 0,6-0,8) for CHP group and 0,83 (CI 95% 0,66 - 0,92) for IPF (p = 0,027). Nevertheless this difference disappeared using Cox proportional hazard analysis, the adjusted HR for survival among CHP patients was 0,53 (CI 95% 0,25-1,15) (p = 0,11). There was no difference in functional evolution between the two groups. KM rate for a decline more than or equal to 10% was 0,64 for CHP (CI 95% 0,43-0,79) and 0,78 for IPF (IC 95% 0,6-0,88) (p = 0,22). This observation did not change after using Cox proportional hazard analysis. Conclusions: Our study shows that both IPF and CHP are fibrosing interstitial diseases with a similar evolution and survival. It might be possible that therapeutic approach in patients with CHP should change in the light of these observations. (C) 2019 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 50 条
  • [41] Acute Exacerbation and Proposed Criteria for Progressive Pulmonary Fibrosis in Patients with Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
    Okuda, Ryo
    Takemura, Tamiko
    Misumi, Toshihiro
    Nagasawa, Ryo
    Iwasawa, Tae
    Baba, Tomohisa
    Hagiwara, Eri
    Ogura, Takashi
    RESPIRATION, 2023, 102 (09) : 803 - 812
  • [42] 5-methyladenosine regulators play a crucial role in development of chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis
    Zhou, Yiyi
    Hu, Zhenli
    Sun, Qinying
    Dong, Yuchao
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [43] 5-methyladenosine regulators play a crucial role in development of chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis
    Yiyi Zhou
    Zhenli Hu
    Qinying Sun
    Yuchao Dong
    Scientific Reports, 13
  • [44] Tissue Expression Of Th2 Markers: Comparison Between Idiopathic Pulmonary Fibrosis And Fibrotic Hypersensitivity Pneumonitis
    Fraccaro, A.
    Montero-Fernandez, A.
    Nicholson, A. G.
    Maher, T. M.
    Wells, A. U.
    Sestini, P.
    Kelleher, P.
    Saetta, M.
    Renzoni, E. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [45] Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
    Sobiecka, Malgorzata
    Szturmowicz, Monika
    Lewandowska, Katarzyna B.
    Baranska, Inga
    Zimna, Katarzyna
    Lyzwa, Ewa
    Dybowska, Malgorzata
    Langfort, Renata
    Radwan-Rohrenschef, Piotr
    Rozy, Adriana
    Tomkowski, Witold Z.
    DIAGNOSTICS, 2023, 13 (05)
  • [46] Immunoglobulin free light chains are increased in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis patients
    Kormelink, Groot T.
    Pardo, A.
    Knipping, K.
    Buendia-Roldan, I
    Garcia-de-Alba, C.
    Blokhuis, B.
    Selman, M.
    Redegeld, F.
    ALLERGY, 2011, 66 : 462 - 462
  • [47] BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis
    d'Alessandro, Miriana
    Bergantini, Laura
    Cameli, Paolo
    Lanzarone, Nicola
    Perillo, Felice
    Perrone, Anna
    Bargagi, Elena
    LIFE SCIENCES, 2020, 256
  • [48] Pulmonary fibrosis in young patients with hypersensitivity pneumonitis
    Elzbieta, Wiatr
    Elzbieta, Radzikowska
    Jacek, Pawlowski
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2006, 23 (02) : 149 - 149
  • [49] A Machine Learning-based Radiomics Model for Differentiating Idiopathic Pulmonary Fibrosis and Chronic Hypersensitivity Pneumonitis Thorough Pyradiomics
    Onodera, Y.
    Kitamura, H.
    Haga, A.
    Sekine, A.
    Yamada, S.
    Tabata, E.
    Iwasawa, T.
    Ogura, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [50] Pulmonary Hypertension in Chronic Hypersensitivity Pneumonitis
    Koschel, Dirk S.
    Cardoso, Carlos
    Wiedemann, Baerbel
    Hoeffken, Gert
    Halank, Michael
    LUNG, 2012, 190 (03) : 295 - 302